| Helen Christina Ballestas, PHD, RN, ANP | |
|
201 Oakbrook Ln Ste 255, Summerville, SC 29485-7538 | |
| (438) 512-0008 | |
| (843) 850-2003 |
| Full Name | Helen Christina Ballestas |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 13 Years |
| Location | 201 Oakbrook Ln Ste 255, Summerville, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144511601 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LA2200X | Nurse Practitioner - Adult Health | 20480 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trident Medical Center | Charleston, SC | Hospital |
| Roper St Francis Hospital-berkely Inc | Moncks corner, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fetter Health Care Network Inc | 9032215199 | 19 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Entity Name | Palmetto Primary Care Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073234928 PECOS PAC ID: 4880508068 Enrollment ID: O20031113000287 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003827304 PECOS PAC ID: 9032215199 Enrollment ID: O20070507000192 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982124301 PECOS PAC ID: 9032215199 Enrollment ID: O20171228002000 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518454818 PECOS PAC ID: 9032215199 Enrollment ID: O20190118001672 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659872059 PECOS PAC ID: 9032215199 Enrollment ID: O20190930000858 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Entity Name | Fetter Health Care Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457007841 PECOS PAC ID: 9032215199 Enrollment ID: O20221012001595 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Helen Christina Ballestas, PHD, RN, ANP Po Box 530062, Atlanta, GA 30353-0062 Ph: (436) 956-0718 | Helen Christina Ballestas, PHD, RN, ANP 201 Oakbrook Ln Ste 255, Summerville, SC 29485-7538 Ph: (438) 512-0008 |
News Archive
Ligand Pharmaceuticals Incorporated announces the signing of a license agreement with Ethicor Pharma Ltd. for the manufacture and distribution of the oral formulation of lasofoxifene in the European Economic Area, Switzerland and the Indian Subcontinent.
Clinical trials start this week for a stroke drug initially created by a team led by scientists at The Scripps Research Institute and the University of Southern California (USC), and further developed by biotech company ZZ Biotech.
"India has not had a case of polio in nine months, raising hopes the country is on the verge of defeating the disease, health officials said Monday," the Associated Press reports.
Researchers at the University of Texas Medical Branch, Galveston, have developed a new platform that can rapidly test neutralizing antibody activity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and perform high-throughput screening of potential antiviral agents.
University of Michigan researchers have discovered the rules that dictate the three-dimensional shapes of RNA molecules, rules that are based not on complex chemical interactions but simply on geometry.
› Verified 1 days ago
Nicholas Arthur Hathaway, FNP, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 213 W 4th St N, Summerville, SC 29483 Phone: 843-873-0681 | |
Marie Davis Rataj, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 92 Springview Lane, South Carolina Sleep Medicine, Summerville, SC 29485 Phone: 843-871-4006 Fax: 843-871-4074 | |
Mrs. Caroline M Yerich, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 809 N Cedar St, Summerville, SC 29483 Phone: 843-871-9440 Fax: 843-871-5932 | |
Susan Marie Taylor, MSN, APRN, PMHNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 148 Apache Dr, Summerville, SC 29483 Phone: 843-708-0694 | |
Kristina M Dibartolo, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 90 Springview Ln # A, Summerville, SC 29485 Phone: 843-832-9113 Fax: 843-832-9114 | |
Jody Kay Smith, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 89 Old Trolley Rd Ste 200, Summerville, SC 29485 Phone: 737-226-6740 | |
Katherine Ellis, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2016 1st Ave, Summerville, SC 29486 Phone: 843-432-3109 |